Inhibition of PI3K increases oxaliplatin sensitivity in cholangiocarcinoma cells
Abstract Background Resistance of cholangiocarcinoma to chemotherapy is a major problem in cancer treatment.The mechanism of resistance is believed to involve phosphoinositide-3- kinase (PI3K)/Akt activation.Although the platinum-containing compound oxaliplatin has lorenametaute.com been extensively used in the treatment of several solid tumors, re